# Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine

> **NCT05547815** · PHASE4 · COMPLETED · sponsor: **Changchun Zhuoyi Biological Co., Ltd** · enrollment: 149 (actual)

## Conditions studied

- Rabies
- Antibody

## Interventions

- **BIOLOGICAL:** 5 doses program

## Key facts

- **NCT ID:** NCT05547815
- **Lead sponsor:** Changchun Zhuoyi Biological Co., Ltd
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-11
- **Primary completion:** 2020-12-17
- **Final completion:** 2021-11-08
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2022-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05547815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05547815, "Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05547815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*